• Markets
• News
• Learn

SiriusPoint’s FY 2025 earnings in focus

SiriusPoint (SPNT) closed FY 2025 with fourth quarter revenue of US$762.3 million and basic EPS of US$2.05, alongside net income of US$239.9 million. This marked a clear break from the loss reported in the prior year’s fourth quarter, when revenue was US$638.7 million and EPS was US$0.11 with net income of US$17.8 million. Over the last twelve months in this dataset, revenue has moved from US$2.66 billion and EPS of US$1.06 to US$2.98 billion and EPS of US$3.80, with net income rising from US$176.2 million to US$443.3 million, although that trailing figure includes a US$222.4 million one off gain. For investors, the headline here is a business reporting strong profitability and healthier margins on the latest numbers, even if part of that uplift is tied to non recurring items.

With the scorecard on the table, the next step is to see how these results line up with the widely held narratives around SiriusPoint, and where the data pushes back against the prevailing stories.

See what the community is saying about SiriusPoint

Net margin almost doubles year on year

• On a trailing basis, SiriusPoint's net profit margin sits at 14.9% compared with 6.6% a year earlier, alongside trailing net income of US$443.3 million on US$2.98b of revenue.
• Consensus narrative highlights disciplined underwriting and 11 consecutive quarters of underwriting profits, and the margin shift toward 14.9% gives some backing to that. However,
  • the 151.6% earnings growth over the past year is boosted by a US$222.4 million one off gain, so part of the margin uplift is tied to a non recurring item rather than purely ongoing operations,
  • and the focus on specialty lines and Accident & Health that analysts see as a margin support is still being tested across different combined ratios, which ranged from 91.4% in 2025 Q1 to the mid 80s later in the year.

151.6% earnings growth meets bearish forecasts

• Trailing earnings grew 151.6% over the last year to US$443.3 million, but forecasts in this dataset point to earnings declining about 19.4% per year over the next three years.
• Bears argue that catastrophe risk, competition and reliance on MGA partnerships could pressure profitability despite the recent strong figures, and that concern lines up with
  • the forecast multi year earnings decline of roughly 19.4% a year, which sits in sharp contrast to the very strong trailing growth rate,
  • and the fact that last twelve month earnings include a US$222.4 million one off gain, so the current 14.9% margin may not fully reflect the earnings pattern that those more cautious forecasts are built around.

Low 5.6x P/E versus DCF fair value

• The company trades on a P/E of 5.6x compared with 6.9x for peers and 12.1x for the wider US Insurance industry, and a DCF fair value of US$34.94 sits well above the current share price of US$21.25.
• Bullish investors point to disciplined underwriting and expanding MGA partnerships as reasons the current valuation might understate future earnings power, and the numbers give them some support, although with caveats:
  • the combination of a lower P/E multiple and a DCF fair value of US$34.94 versus a US$21.25 share price suggests the stock is priced below that modelled cash flow value in this dataset,
  • yet the major risk flag that earnings are expected to decline around 19.4% a year, together with the US$222.4 million one off gain in the trailing period, means part of that apparent value case depends on how much weight you give to current earnings versus the forecast path.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for SiriusPoint on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this combination of strong recent numbers and cautious forecasts seems mixed to you, that is precisely why the data is so important right now. Consider it carefully and review the balance of 3 key rewards and 2 important warning signs.

See What Else Is Out There

The key question here is that trailing earnings and margins rely on a US$222.4 million one off gain, while forecasts indicate roughly a 19.4% annual earnings decline.

If that earnings uncertainty and potential volatility make you cautious, you might want to spread your attention across 80 resilient stocks with low risk scores, which aim to prioritize resilience and reduce unpleasant surprises.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com